Published in Blood on June 13, 2006
Platelet depletion and aspirin treatment protect mice in a two-event model of transfusion-related acute lung injury. J Clin Invest (2009) 3.08
Fresh red blood cell transfusion and short-term pulmonary, immunologic, and coagulation status: a randomized clinical trial. Am J Respir Crit Care Med (2012) 2.47
A paradoxical role for myeloid-derived suppressor cells in sepsis and trauma. Mol Med (2010) 2.06
Identification of lipids that accumulate during the routine storage of prestorage leukoreduced red blood cells and cause acute lung injury. Transfusion (2011) 1.87
Plasma from stored packed red blood cells and MHC class I antibodies causes acute lung injury in a 2-event in vivo rat model. Blood (2009) 1.49
Characterization of the human neutrophil alloantigen-3a. Nat Med (2009) 1.43
Extracellular DNA traps are associated with the pathogenesis of TRALI in humans and mice. Blood (2012) 1.42
The Epidemiology of Transfusion-related Acute Lung Injury Varies According to the Applied Definition of Lung Injury Onset Time. Ann Am Thorac Soc (2015) 1.39
Pilot analysis of cytokines levels in stored granulocyte-colony-stimulating factor-mobilized peripheral blood stem cell concentrates. Transfusion (2010) 1.38
Transfusion-related acute lung injury (TRALI): current concepts and misconceptions. Blood Rev (2009) 1.26
The platelet as an immune cell-CD40 ligand and transfusion immunomodulation. Immunol Res (2009) 1.25
Transfusion-related acute lung injury (TRALI): a clinical review with emphasis on the critically ill. Br J Haematol (2009) 1.23
Adverse effects of plasma transfusion. Transfusion (2012) 1.23
Association between serum soluble CD40 ligand levels and mortality in patients with severe sepsis. Crit Care (2011) 1.23
Transfusion immunomodulation--the case for leukoreduced and (perhaps) washed transfusions. Blood Cells Mol Dis (2012) 1.22
Pulmonary transfusion reactions. Transfus Med Hemother (2008) 1.19
Effects of storage of red cells. Transfus Med Hemother (2008) 1.16
New frontiers in transfusion biology: identification and significance of mediators of morbidity and mortality in stored red blood cells. Transfusion (2011) 1.11
Analysis of a high-throughput HLA antibody screening assay for use with platelet donors. Transfusion (2008) 1.11
Experimental prestorage filtration removes antibodies and decreases lipids in RBC supernatants mitigating TRALI in vivo. Blood (2014) 1.11
Platelets influence vascularized organ transplants from start to finish. Am J Transplant (2008) 1.08
Platelet proteome changes associated with diabetes and during platelet storage for transfusion. J Proteome Res (2009) 1.07
The role of neutrophils in the pathogenesis of transfusion-related acute lung injury. Transfus Med Rev (2009) 1.06
MHC class I-specific antibody binding to nonhematopoietic cells drives complement activation to induce transfusion-related acute lung injury in mice. J Exp Med (2011) 1.06
Pathogen Inactivation of Platelet and Plasma Blood Components for Transfusion Using the INTERCEPT Blood System™ Transfus Med Hemother (2011) 1.04
Microparticles in stored red blood cells as potential mediators of transfusion complications. Transfusion (2011) 1.04
Proteomic analysis of the supernatant of red blood cell units: the effects of storage and leucoreduction. Vox Sang (2013) 1.02
Effects of blood products on inflammatory response in endothelial cells in vitro. PLoS One (2012) 0.99
Platelet transfusions: impact on hemostasis, thrombosis, inflammation and clinical outcomes. Thromb Res (2010) 0.97
Cell-derived microparticles in stored blood products: innocent-bystanders or effective mediators of post-transfusion reactions? Blood Transfus (2012) 0.95
Mirasol Pathogen Reduction Technology treatment does not affect acute lung injury in a two-event in vivo model caused by stored blood components. Vox Sang (2009) 0.94
TRALI--definition, mechanisms, incidence and clinical relevance. Best Pract Res Clin Anaesthesiol (2007) 0.92
Age of blood and recipient factors determine the severity of transfusion-related acute lung injury (TRALI). Crit Care (2012) 0.91
Transfusion-related acute lung injury in multiple traumatized patients. Caspian J Intern Med (2012) 0.91
Platelet CD40L at the interface of adaptive immunity. Thromb Res (2010) 0.90
Lower serum endocan levels are associated with the development of acute lung injury after major trauma. J Crit Care (2011) 0.89
Amantadine inhibits platelet-activating factor induced clathrin-mediated endocytosis in human neutrophils. Am J Physiol Cell Physiol (2009) 0.89
Prognosis of ulcerative colitis differs between patients with complete and partial mucosal healing, which can be predicted from the platelet count. World J Gastroenterol (2014) 0.87
The signaling role of CD40 ligand in platelet biology and in platelet component transfusion. Int J Mol Sci (2014) 0.86
The pro-inflammatory effects of platelet contamination in plasma and mitigation strategies for avoidance. Vox Sang (2011) 0.86
The effects of pneumatic tube transport on fresh and stored platelets in additive solution. Blood Transfus (2013) 0.85
Lack of significant de novo HLA allosensitization in ventricular assist device recipients transfused with leukoreduced, ABO identical blood products. Hum Immunol (2009) 0.85
Lack of evidence of CD40 ligand involvement in transfusion-related acute lung injury. Clin Exp Immunol (2011) 0.85
Platelet transfusion - the new immunology of an old therapy. Front Immunol (2015) 0.84
Platelets and Their Interactions with Other Immune Cells. Compr Physiol (2015) 0.83
Parietal and intravascular innate mechanisms of vascular inflammation. Arthritis Res Ther (2015) 0.82
Real-Time Live Confocal Fluorescence Microscopy as a New Tool for Assessing Platelet Vitality. Transfus Med Hemother (2010) 0.82
Effect of transfusion of fresh frozen plasma on parameters of endothelial condition and inflammatory status in non-bleeding critically ill patients: a prospective substudy of a randomized trial. Crit Care (2015) 0.82
Hemostatic function of apheresis platelets stored at 4°C and 22°C. Shock (2014) 0.82
Platelet storage and transfusions: new concerns associated with an old therapy. Drug Discov Today Dis Mech (2011) 0.80
A computerized prediction model of hazardous inflammatory platelet transfusion outcomes. PLoS One (2014) 0.80
Research opportunities in optimizing storage of red blood cell products. Transfusion (2013) 0.80
Respiratory burst function of ovine neutrophils. BMC Immunol (2009) 0.80
Biological response modifiers in photochemically pathogen-reduced versus untreated apheresis platelet concentrates. Transfusion (2012) 0.80
Are polymorphisms of the immunoregulatory factor CD40LG implicated in acute transfusion reactions? Sci Rep (2014) 0.80
Evaluation of platelet function during extended storage in additive solution, prepared in a new container that allows manual buffy-coat platelet pooling and leucoreduction in the same system. Blood Transfus (2012) 0.80
Bioactive lipids from stored cellular blood components: in vitro method is crucial for proper interpretation. Transfusion (2012) 0.79
High Flow-Mediated Vasodilatation Predicts Pulmonary Edema in Liver Transplant Patients. Zhonghua Minguo Xin Zang Xue Hui Za Zhi (2013) 0.79
CD40 ligand (CD154) involvement in platelet transfusion reactions. Transfus Clin Biol (2012) 0.79
Experimental models of transfusion-related acute lung injury. Transfus Med Rev (2011) 0.78
Resveratrol preserves the function of human platelets stored for transfusion. Br J Haematol (2015) 0.77
Statin islands and PPAR ligands in platelets. Arterioscler Thromb Vasc Biol (2009) 0.77
Antiplatelet antibody may cause delayed transfusion-related acute lung injury. Int J Gen Med (2011) 0.76
Soluble CD40 ligand, a mediator of sepsis or of transfusion-related adverse effects? Crit Care (2011) 0.76
Levels of human platelet-derived soluble CD40 ligand depend on haplotypes of CD40LG-CD40-ITGA2. Sci Rep (2016) 0.76
Developmental changes in soluble CD40 ligand. J Pediatr (2007) 0.76
Platelet Vascular Endothelial Growth Factor is a Potential Mediator of Transfusion-Related Acute Lung Injury. J Pulm Respir Med (2015) 0.75
Storage of Red Blood Cells and Transfusion-Related Acute Lung Injury. J Anesth Crit Care (2014) 0.75
Fatal transfusion related acute lung injury following coronary artery by-pass surgery: a case report. Cases J (2008) 0.75
Transfusion-Related Acute Lung Injury (TRALI): Report of 2 Cases and a Review of The Literature. Ochsner J (2008) 0.75
Morphological and flow-cytometric analysis of haemin-induced human neutrophil activation: implications for transfusion-related acute lung injury. Blood Transfus (2012) 0.75
Red blood cells, transfusion-related acute lung injury, and lipids: a role for liporeduction? Transfusion (2011) 0.75
Proceedings of German Society for Stem Cell Research - 2010 (PGSSCR) (5th Annual Meeting) Invited speakers - IS1. J Stem Cells Regen Med (2010) 0.75
The accumulation of lipids and proteins during red blood cell storage: the roles of leucoreduction and experimental filtration. Blood Transfus (2017) 0.75
Enhancement of soluble CD28 levels in the serum of Graves' disease. Cent Eur J Immunol (2014) 0.75
The mystery of transfusion-related acute lung injury. Transfusion (2011) 0.75
Is Coagulopathy an Appropriate Therapeutic Target During Critical Illness Such as Trauma or Sepsis? Shock (2017) 0.75
Biological defense mechanisms. The production by leukocytes of superoxide, a potential bactericidal agent. J Clin Invest (1973) 17.56
The biochemical basis of phagocytosis. I. Metabolic changes during the ingestion of particles by polymorphonuclear leukocytes. J Biol Chem (1959) 17.39
Three-dimensional segregation of supramolecular activation clusters in T cells. Nature (1998) 14.14
Toward an understanding of transfusion-related acute lung injury: statement of a consensus panel. Transfusion (2004) 4.48
Transfusion-related acute lung injury: definition and review. Crit Care Med (2005) 3.98
Microfluorometric detection of deoxyribonucleic acid replication in human metaphase chromosomes. Proc Natl Acad Sci U S A (1973) 3.76
Transfusion-related acute lung injury: epidemiology and a prospective analysis of etiologic factors. Blood (2002) 3.18
CD40L stabilizes arterial thrombi by a beta3 integrin--dependent mechanism. Nat Med (2002) 2.77
The association of biologically active lipids with the development of transfusion-related acute lung injury: a retrospective study. Transfusion (1997) 2.67
Plasma and lipids from stored packed red blood cells cause acute lung injury in an animal model. J Clin Invest (1998) 2.37
Multiple organ system failure and infection in adult respiratory distress syndrome. Ann Intern Med (1983) 2.28
CD40 is constitutively expressed on platelets and provides a novel mechanism for platelet activation. Circ Res (2003) 2.27
Partial characterization of lipids that develop during the routine storage of blood and prime the neutrophil NADPH oxidase. J Lab Clin Med (1994) 2.13
Innate immune recognition and control of adaptive immune responses. Semin Immunol (1998) 1.92
Structural comparison of the two distinct sugar binding sites in wheat germ agglutinin isolectin II. J Mol Biol (1984) 1.85
Plasma and lipids from stored platelets cause acute lung injury in an animal model. Transfusion (2003) 1.79
The inflammatory action of CD40 ligand (CD154) expressed on activated human platelets is temporally limited by coexpressed CD40. Blood (2001) 1.75
A randomized trial on the efficacy of an autologous blood drainage and transfusion device in patients undergoing elective knee arthroplasty. Transfusion (1992) 1.62
The effect of prestorage WBC reduction on the rates of febrile nonhemolytic transfusion reactions to platelet concentrates and RBC. Transfusion (2004) 1.56
The role of the lung in postinjury multiple organ failure. Surgery (2005) 1.54
A prospective study to identify the risk factors associated with acute reactions to platelet and red cell transfusions. Transfusion (1993) 1.52
The two-event construct of postinjury multiple organ failure. Shock (2005) 1.46
A two-insult in vitro model of PMN-mediated pulmonary endothelial damage: requirements for adherence and chemokine release. Am J Physiol Cell Physiol (2002) 1.39
A randomized trial of washed red blood cell and platelet transfusions in adult acute leukemia [ISRCTN76536440]. BMC Blood Disord (2004) 1.39
Platelet derived CD154 (CD40 ligand) and febrile responses to transfusion. Lancet (2001) 1.29
An association of soluble CD40 ligand (CD154) with adverse reactions to platelet transfusions. Transfusion (2006) 1.28
The role of CD40 in peripheral T cell tolerance and immunity. J Mol Med (Berl) (2000) 1.26
Lysophosphatidylcholines prime the NADPH oxidase and stimulate multiple neutrophil functions through changes in cytosolic calcium. J Leukoc Biol (2003) 1.25
Platelet chemokines and their receptors: what is their relevance to platelet storage and transfusion practice? Transfus Med (2001) 1.19
CD40: a growing cytoplasmic tale. Sci STKE (2004) 1.19
Primed stimulation of isolated perfused rabbit lung by endotoxin and platelet activating factor induces enhanced production of thromboxane and lung injury. J Clin Invest (1990) 1.19
CD40 plays a crucial role in lipopolysaccharide-induced acute lung injury. Am J Respir Cell Mol Biol (2003) 1.15
Assembly and activation of the NADPH:O2 oxidoreductase in human neutrophils after stimulation with phorbol myristate acetate. J Biol Chem (1990) 1.10
Disruption of the CD40-CD40 ligand system prevents an oxygen-induced respiratory distress syndrome. Am J Pathol (1998) 1.08
Preanalytical variability in laboratory testing: influence of the blood drawing technique. Clin Chem Lab Med (2005) 1.02
ARDS-like lung injury produced by endotoxin in platelet-activating factor-primed rats. J Appl Physiol (1985) (1993) 0.98
Apheresis-induced platelet activation:comparison of three types of cell separators. Transfusion (2000) 0.96
Ionomycin causes activation of p38 and p42/44 mitogen-activated protein kinases in human neutrophils. Am J Physiol Cell Physiol (2001) 0.95
ICAM-1-CD18 interaction mediates neutrophil cytotoxicity through protease release. Am J Physiol (1998) 0.92
The CD40-CD40 ligand system: a potential therapeutic target in atherosclerosis. Curr Opin Investig Drugs (2001) 0.91
CD40 ligation triggers COX-2 expression in endothelial cells: evidence that CD40-mediated IL-6 synthesis is COX-2-dependent. Inflamm Res (2003) 0.89
The causes and treatment of reactions to platelet transfusions. Transfusion (2003) 0.88
Formyl-Met-Leu-Phe induces calcium-dependent tyrosine phosphorylation of Rel-1 in neutrophils. Cell Calcium (2003) 0.87
Immunotherapy targeting the CD40/CD154 costimulatory pathway for treatment of autoimmune disease. Autoimmunity (2004) 0.87
2 A crystal structure of an extracellular fragment of human CD40 ligand. Structure (1995) 0.85
Receptor-mediated calcium entry is required for maximal effects of platelet activating factor primed responses in human neutrophils. Biochem Biophys Res Commun (1997) 0.85
CD40 and CD40L expression in the chicken embryo aorta: possible role in the endothelial-mesenchymal transdifferentiation process. Anat Rec A Discov Mol Cell Evol Biol (2003) 0.84
Transfusion-related acute lung injury (TRALI) following platelet transfusion in a patient receiving high-dose interleukin-2 for treatment of metastatic renal cell carcinoma. Transfus Apher Sci (2003) 0.83
TRALI and massive transfusion. Resuscitation (2003) 0.82
Transfusion-related acute lung injury following random donor platelet transfusion: a report of two cases. Vox Sang (1997) 0.80
Granule secretion markers on fluid-phase platelets in whole blood perfused through capillary tubing. J Biomed Mater Res (1994) 0.79
Transfusion-related acute lung injury: definition and review. Crit Care Med (2005) 3.98
Antiplatelet therapy is associated with decreased transfusion-associated risk of lung dysfunction, multiple organ failure, and mortality in trauma patients. Crit Care Med (2013) 3.65
Transfusion-related acute lung injury: epidemiology and a prospective analysis of etiologic factors. Blood (2002) 3.18
Transfusion-related acute lung injury. Blood (2004) 2.65
Why chronic wounds will not heal: a novel hypothesis. Wound Repair Regen (2008) 2.58
Increased rate of infection associated with transfusion of old blood after severe injury. Arch Surg (2002) 2.34
The injured child is resistant to multiple organ failure: a different inflammatory response? J Trauma (2002) 2.26
The Pseudomonas aeruginosa quorum-sensing molecule N-(3-oxododecanoyl)homoserine lactone contributes to virulence and induces inflammation in vivo. J Bacteriol (2002) 2.18
The intention-to-treat principle in clinical trials and meta-analyses of leukoreduced blood transfusions in surgical patients. Transfusion (2007) 2.12
Structural organization of the neutrophil NADPH oxidase: phosphorylation and translocation during priming and activation. J Leukoc Biol (2005) 1.94
Rapid necrotic killing of polymorphonuclear leukocytes is caused by quorum-sensing-controlled production of rhamnolipid by Pseudomonas aeruginosa. Microbiology (2007) 1.88
Identification of lipids that accumulate during the routine storage of prestorage leukoreduced red blood cells and cause acute lung injury. Transfusion (2011) 1.87
Blood transfusions, thrombosis, and mortality in hospitalized patients with cancer. Arch Intern Med (2008) 1.85
Triggers of hospitalization for venous thromboembolism. Circulation (2012) 1.76
Thy-1 expression in human fibroblast subsets defines myofibroblastic or lipofibroblastic phenotypes. Am J Pathol (2003) 1.75
Effects of antibiotics on quorum sensing in Pseudomonas aeruginosa. Antimicrob Agents Chemother (2008) 1.67
Washing red blood cells and platelets transfused in cardiac surgery reduces postoperative inflammation and number of transfusions: results of a prospective, randomized, controlled clinical trial. Pediatr Crit Care Med (2012) 1.67
HMGB1 is markedly elevated within 6 hours of mechanical trauma in humans. Shock (2009) 1.64
Allogeneic blood transfusions explain increased mortality in women after coronary artery bypass graft surgery. Am Heart J (2006) 1.62
Hospital variation in transfusion and infection after cardiac surgery: a cohort study. BMC Med (2009) 1.58
Transfusion of cell saver salvaged blood in neonates and infants undergoing open heart surgery significantly reduces RBC and coagulant product transfusions and donor exposures: results of a prospective, randomized, clinical trial. Pediatr Crit Care Med (2013) 1.55
Human bone marrow megakaryocytes and platelets express PPARgamma, and PPARgamma agonists blunt platelet release of CD40 ligand and thromboxanes. Blood (2004) 1.55
Autologous transfusion. BMJ (2002) 1.52
Nebulized hypertonic saline attenuates acute lung injury following trauma and hemorrhagic shock via inhibition of matrix metalloproteinase-13. Crit Care Med (2012) 1.51
Fibrinolysis greater than 3% is the critical value for initiation of antifibrinolytic therapy. J Trauma Acute Care Surg (2013) 1.49
Plasma from stored packed red blood cells and MHC class I antibodies causes acute lung injury in a 2-event in vivo rat model. Blood (2009) 1.49
Impact of ABO mismatching on the outcomes of allogeneic related and unrelated blood and marrow stem cell transplantations for hematologic malignancies: IPD-based meta-analysis of cohort studies. Transfusion (2009) 1.47
Hypertonic saline inhibits arachidonic acid priming of the human neutrophil oxidase. J Surg Res (2011) 1.44
Hyperfibrinolysis, physiologic fibrinolysis, and fibrinolysis shutdown: the spectrum of postinjury fibrinolysis and relevance to antifibrinolytic therapy. J Trauma Acute Care Surg (2014) 1.43
Aspirin resistance following pediatric cardiac surgery. Thromb Res (2010) 1.42
Quorum sensing and virulence of Pseudomonas aeruginosa during lung infection of cystic fibrosis patients. PLoS One (2010) 1.42
Large Variation in Blood Transfusion Use After Colorectal Resection: A Call to Action. Dis Colon Rectum (2016) 1.40
A two-insult in vitro model of PMN-mediated pulmonary endothelial damage: requirements for adherence and chemokine release. Am J Physiol Cell Physiol (2002) 1.39
A randomized trial of washed red blood cell and platelet transfusions in adult acute leukemia [ISRCTN76536440]. BMC Blood Disord (2004) 1.39
Early platelet dysfunction: an unrecognized role in the acute coagulopathy of trauma. J Am Coll Surg (2012) 1.35
Silver against Pseudomonas aeruginosa biofilms. APMIS (2007) 1.33
An association of soluble CD40 ligand (CD154) with adverse reactions to platelet transfusions. Transfusion (2006) 1.28
Transfusion-related acute lung injury (TRALI): a clinical review with emphasis on the critically ill. Br J Haematol (2009) 1.23
Transfusion immunomodulation--the case for leukoreduced and (perhaps) washed transfusions. Blood Cells Mol Dis (2012) 1.22
Platelet-activating factor-induced clathrin-mediated endocytosis requires beta-arrestin-1 recruitment and activation of the p38 MAPK signalosome at the plasma membrane for actin bundle formation. J Immunol (2006) 1.18
Platelets and megakaryocytes contain functional nuclear factor-kappaB. Arterioscler Thromb Vasc Biol (2009) 1.13
Peroxisome proliferator-activated receptor gamma and retinoid X receptor transcription factors are released from activated human platelets and shed in microparticles. Thromb Haemost (2008) 1.12
Inactivation of the rhlA gene in Pseudomonas aeruginosa prevents rhamnolipid production, disabling the protection against polymorphonuclear leukocytes. APMIS (2009) 1.12
An association of ABO non-identical platelet and cryoprecipitate transfusions with altered red cell transfusion needs in surgical patients. Vox Sang (2011) 1.11
15-deoxy-delta12,14-PGJ2 enhances platelet production from megakaryocytes. Blood (2008) 1.11
New frontiers in transfusion biology: identification and significance of mediators of morbidity and mortality in stored red blood cells. Transfusion (2011) 1.11
Differentiation of enzymatic from platelet hypercoagulability using the novel thrombelastography parameter delta (delta). J Surg Res (2010) 1.09
Arachidonic acid in postshock mesenteric lymph induces pulmonary synthesis of leukotriene B4. J Appl Physiol (1985) (2008) 1.09
Goal-directed Hemostatic Resuscitation of Trauma-induced Coagulopathy: A Pragmatic Randomized Clinical Trial Comparing a Viscoelastic Assay to Conventional Coagulation Assays. Ann Surg (2016) 1.07
Functional fibrinogen assay indicates that fibrinogen is critical in correcting abnormal clot strength following trauma. Shock (2013) 1.07
Platelet proteome changes associated with diabetes and during platelet storage for transfusion. J Proteome Res (2009) 1.07
Differential effects of plasma and red blood cell transfusions on acute lung injury and infection risk following liver transplantation. Liver Transpl (2011) 1.06
The role of neutrophils in the pathogenesis of transfusion-related acute lung injury. Transfus Med Rev (2009) 1.06
Alterations of platelet function and clot formation kinetics after in vitro exposure to anti-A and -B. Transfusion (2012) 1.04
WBC reduction of RBC transfusions is associated with a decreased incidence of RBC alloimmunization. Transfusion (2003) 1.03
Complex expression pattern of the Barth syndrome gene product tafazzin in human cell lines and murine tissues. Biochem Cell Biol (2004) 1.03
Systemic neutrophil priming by lipid mediators in post-shock mesenteric lymph exists across species. J Trauma (2004) 1.03
Transfusion-related acute lung injury in ICU patients admitted with gastrointestinal bleeding. Intensive Care Med (2010) 1.02
Platelets are dominant contributors to hypercoagulability after injury. J Trauma Acute Care Surg (2013) 1.02
Nuclear emancipation: a platelet tour de force. Sci Signal (2010) 1.01
A standardized technique for performing thromboelastography in rodents. Shock (2011) 1.01
Physiological levels of interleukin-18 stimulate multiple neutrophil functions through p38 MAP kinase activation. J Leukoc Biol (2002) 1.01
Viscoelastic clot strength predicts coagulation-related mortality within 15 minutes. Surgery (2011) 1.00
Acute hypoxemia in humans enhances the neutrophil inflammatory response. Shock (2002) 0.99
On-road exposure to highway aerosols. 2. Exposures of aged, compromised rats. Inhal Toxicol (2004) 0.98
Optimizing platelet transfusion therapy. Blood Rev (2004) 0.98
Pathologic metabolism: an exploratory study of the plasma metabolome of critical injury. J Trauma Acute Care Surg (2015) 0.98
Platelet transfusions: impact on hemostasis, thrombosis, inflammation and clinical outcomes. Thromb Res (2010) 0.97
Plasma first in the field for postinjury hemorrhagic shock. Shock (2014) 0.97
Fibrinogen gamma' chain carboxy terminal peptide selectively inhibits the intrinsic coagulation pathway. Br J Haematol (2007) 0.96
Does the storage duration of blood products affect outcomes in critically ill patients? Transfusion (2011) 0.96
Intravenous delivery of the plasma fraction of stored packed erythrocytes promotes pancreatic cancer growth in immunocompetent mice. Cancer (2010) 0.96
Proteomic analyses of human plasma: Venus versus Mars. Transfusion (2011) 0.95
ABO incompatibility between donor and recipient and clinical outcomes in allogeneic stem cell transplantation. Leuk Res (2003) 0.94
Alteration of the postinjury hyperinflammatory response by means of resuscitation with a red cell substitute. J Trauma (2003) 0.94
Transfusion immunomodulation from a clinical perspective: an update. Expert Rev Hematol (2013) 0.94
Lysophosphatidylcholines activate G2A inducing G(αi)₋₁-/G(αq/)₁₁- Ca²(+) flux, G(βγ)-Hck activation and clathrin/β-arrestin-1/GRK6 recruitment in PMNs. Biochem J (2010) 0.93
Overwhelming tPA release, not PAI-1 degradation, is responsible for hyperfibrinolysis in severely injured trauma patients. J Trauma Acute Care Surg (2016) 0.93
Activation state of stromal inflammatory cells in murine metastatic pancreatic adenocarcinoma. Am J Physiol Regul Integr Comp Physiol (2012) 0.92
Age of blood and recipient factors determine the severity of transfusion-related acute lung injury (TRALI). Crit Care (2012) 0.91
Short-term effects of air temperature on blood markers of coagulation and inflammation in potentially susceptible individuals. Occup Environ Med (2012) 0.90
Oncogenic and angiogenic growth factors accumulate during routine storage of apheresis platelet concentrates. Clin Cancer Res (2008) 0.90
Activated platelets in heparinized shed blood: the "second hit" of acute lung injury in trauma/hemorrhagic shock models. Shock (2011) 0.89